ReviewExperimental and therapeutic medicine2024
Saharan dust and respiratory health: Understanding the link between airborne particulate matter and chronic lung diseases (Review).
Review in Experimental and therapeutic medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Spatial variability in the association of ambient PMEnvironmental research · 2026Article
- The prolonged devastation of climate change on public health in Somalia: a silent crisis.Tropical medicine and health · 2025Review
- Desert Sand and Dust Storms and Desert Dust Episodes: Major Patterns to be Accounted for to Protect the Health of Exposed Population: A Review.ACS ES&T air · 2025Review
- Influence of Saharan Dust Intrusions on Respiratory Medication Dispensing.Medical sciences (Basel, Switzerland) · 2025Article
- Impact of Saharan Dust andInternational journal of molecular sciences · 2025Article
- Article
- Burden of Type 2 and Oral Corticosteroids Related Comorbidities in Severe Asthma Patients from the Gulf Countries: A Comparative Study from The ISAR Registry.Journal of asthma and allergy · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Saharan dust storms, which originate from the Sahara desert, have a significant impact on global health, especially on respiratory conditions of populations exposed to fine particulate matter that travels across continents. Dust events, characterized by the transport of mineral dust such as quartz and feldspar, lead to the suspension of particulate matter in the atmosphere, capable of traversing long distances and affecting air quality adversely. Emerging research links these dust episodes with increased incidence and exacerbation of lung diseases, including asthma and chronic obstructive pulmonary disease, especially during peak dust emission seasons from November to March. The present review aims to synthesize existing scientific evidence concerning the respiratory health impacts of Saharan dust, examining the environmental dynamics of dust transmission, the physical and chemical properties of dust particles, and their biological effects on human health. Further, it assesses epidemiological studies and discusses public health strategies for mitigating adverse health outcomes. Given the complexity of interactions between atmospheric dust particles and respiratory health, this review also highlights critical research gaps that need attention to better understand and manage the health risks associated with Saharan dust.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.